Galaxy Surfactants (GALAXYSURF) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
10 Sep, 2026Executive summary
Q4 FY25 saw strong sequential growth in profitability, with consolidated EBITDA up 23% over Q3 to INR 135 crores, and EBITDA per metric ton rising 24% quarter-on-quarter and 5% year-on-year.
Achieved 11% year-over-year growth in consolidated revenue for FY25, reaching ₹4,249.5 crore.
EBITDA for FY25 was ₹510.0 crore, up 2.5% year-over-year, with PAT at ₹304.9 crore, a 1.1% increase.
India and AMET regions experienced flat performance due to lingering demand slowdown and elevated fatty alcohol prices, while the rest of the world delivered double-digit growth, driven by Europe, APAC, North and Latin America.
Operational excellence, cost efficiency, and innovation, including award-winning specialty ingredients, supported margin expansion and global growth.
Financial highlights
FY25 consolidated revenue: ₹4,249.5 crore (+11% YoY); EBITDA: ₹510.0 crore (+2.5% YoY); PAT: ₹304.9 crore (+1.1% YoY).
Q4 FY25 consolidated EBITDA was INR 135 crores, up 23% sequentially; full-year EBITDA reached INR 510 crores, in line with the previous year.
EBITDA per metric ton improved to 21,715 in Q4, a 24% sequential and 5% annual increase; full-year EBITDA per metric ton was 19,868.
PAT margin for FY25 was 7.2%, down from 7.9% in FY24.
Fatty alcohol prices more than doubled YoY, impacting input costs.
Outlook and guidance
Guidance for FY26 volume growth remains at the lower end of the 6%-8% range, given subdued India demand; rest of the world expected to sustain momentum.
EBITDA margin guidance for FY26 is maintained at 20.5%-21.5%.
Management is optimistic about India’s medium-term revival, citing controlled inflation, lower interest rates, and government tax reliefs.
Focus remains on R&D, product innovation, and expanding wallet share with existing and new customers.
Specialty segment and innovation pipeline expected to drive future growth.
Latest events from Galaxy Surfactants
- 8% volume growth and ₹79.72 Cr net profit, with new EU subsidiary and supply chain challenges.GALAXYSURF
Q1 24/25 - ROW and Specialty Care drove growth as margins held firm amid supply chain and price volatility.GALAXYSURF
Q2 24/25 - Q3 volumes fell 1% YoY, margins declined, but international growth and recovery outlook remain.GALAXYSURF
Q3 24/25 - Volumes and revenue rose, but margins narrowed amid input cost and legal risks.GALAXYSURF
Q1 25/26 - Revenue up 24.8% YoY, but margins declined amid higher feedstock costs and tariff headwinds.GALAXYSURF
Q2 25/26 - Q3FY26 revenue up 28% YoY, EBITDA up 13%, PAT down 8.8% due to one-time Labour Code expense.GALAXYSURF
Q3 25/26 - Revenue rose but margins and profit declined amid global disruptions; ₹22/share dividend proposed.GALAXYSURF
Q4 25/26 - Quarterly EBITDA hit INR 252.5 crores, with strong revenue, profit growth, and upgraded guidance.GALAXYSURF
Q1 26/27